Vulnerability in Oracle Life Sciences Central Designer
CVE-2026-21923
- CVSS v3
- 6.5 Medium
- Public exploits
- None known
- EPSS
- 0.003 · 18.5th percentile
- Published
- 2026-01-20
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N.
- Attack Vector
- Network
AV:N - Attack Complexity
- Low
AC:L - Privileges Required
- None
PR:N - User Interaction
- None
UI:N - Scope
- Unchanged
S:U - Confidentiality
- Low
C:L - Integrity
- Low
I:L - Availability
- None
A:N
EPSS exploit prediction
EPSS 0.003, 18.5th percentile (last changed ); unchanged over 30 days. About EPSS.
Affected products
- Oracle Life Sciences Central Designer — versions 7.0.1.0
- Oracle Corporation Life Sciences Central Designer — versions 7.0.1.0
References
- Oracle Advisory (vendor-advisory, Vendor Advisory)